Medications improve health, yet with an aging population & increasing chronic conditions, many use multiple meds. Some treatments can lose effectiveness or pose risks. Associate Prof Lisa McCarthy (she/her) 🇨🇦 of deprescribing.org joins us for a Q&A on #deprescribing: ow.ly/QjeN50SMuX9

Analysis of survey data from 14.9k participants in the US shows a near DOUBLING in the % of older adults using 5+ meds from 1999 to 2020: buff.ly/3WlrUsu Is the ⬆️ in # of ppl living w/ chronic conditions enough to explain this trend? 💭 Visit: buff.ly/48I6Ph9

Add your voice to new #deprescribing testimonials being requested by CADeN. See these oldie but goodies available on our site: deprescribing.org/resources/pati…

Many meds become inappropriate in adults w/ a life expectancy of less than 6 months. Read up on recommendations for #Deprescribing in the last phase of life, compiled from an international Delphi study: buff.ly/4dvhhKI Journal of Pain and Symptom Management (JPSM) Learn more: buff.ly/2pVXiz9

Read about our latest systematic review to inform an evidence-based diuretic #deprescribing guideline! Stopping diuretics could be safe for some patients, but there is a need for higher quality evidence 📖 British Journal of Clinical Pharmacology (BJCP) NERDeprescribing bpspubs.onlinelibrary.wiley.com/doi/full/10.11…

Ever heard of #Deprescribing Equity? Great read from Utibe R. Essien, MD MPH & Michelle S. Keller, PhD in JAMA Internal Medicine: buff.ly/3YJM6XK Let's ensure #deprescribing access for all. Find more tools on how to engage stakeholders in shared-decision making here: buff.ly/416wOM9

Wondering "gaba-why?" See this impt Paula Span article with US Deprescribing Research Network (USDeN)'s Mike Steinman + Matthew Growdon discussing gabapentin's 📈 + role in #prescribingcascades TAKE 🏡 POINTS: 1) Ask gaba-why before starting 2) Think #deprescribing if already onboard 🚢 Emily McDonald

Five things to know about #deprescribing diabetes medications in frail older adults. Check out this useful summary for a refresher on optimal diabetes treatment in this population, and how to conduct safe deprescribing. A great tool developed by Iliana C. Lega & CADeN members

Don't miss this GeriMedRisk update re: 💤 🥱 🛌 management Featuring our Pam Howell + #SophiyaBenjamin 🗓 Sept 10 12-1 pm EST. Register today! CADeN Andrea Murphy

1/n Our deprescribing.org team gets asked about statins A LOT We did a systematic review on statin discontinuation which came out last month in JAGS Join me for few take-aways 👇 #deprescribing #CardioTwitter agsjournals.onlinelibrary.wiley.com/doi/10.1111/jg…

Want to learn more about #statin #deprescribing? 1) Join Wade Thompson as he shares more of this brilliance at ICOD 2 from Sept 26-27. Can't make it to 🇫🇷? Join from 🏡 with online attendance! icod2.sciencesconf.org 2) Keep watching us for news about our #statin guideline.

Are there differences in Potentially Inappropriate Medication use between dementia patients of different ethnicities? Read more: buff.ly/4g7oByj American Geriatrics Society Understanding potential disparities may help better inform targeted interventions to reduce #polypharmacy

Great overview on Preventing Prescribing Cascades from Team Alice | University at Buffalo & Lisa McCarthy (she/her) 🇨🇦! Read about the many tools available now to help detect prescribing cascades & prevent them from occurring: buff.ly/478Jhle JGNJournal Learn more here: buff.ly/3K8fGOl

Check out the new TalkingMeds podcast from PrescQIPP CIC with host Jonathan Underhill⚫️⚪️🎤💙. I will! Funny story: We first bonded at European Association of Hospital Pharmacists Conference 2022 when we navigated an elevator mishap together! We then had this chat: youtu.be/PMKFJhd91ZI?fe… Excited to listen. 👏